271 related articles for article (PubMed ID: 32245113)
1. Looking at New Unexpected Disease Targets in
Mosbah H; Vatier C; Boccara F; Jéru I; Lascols O; Vantyghem MC; Fève B; Donadille B; Sarrazin E; Benabbou S; Inamo J; Ederhy S; Cohen A; Neraud B; Richard P; Picard F; Christin-Maitre S; Redheuil A; Wahbi K; Vigouroux C
Cells; 2020 Mar; 9(3):. PubMed ID: 32245113
[TBL] [Abstract][Full Text] [Related]
2. Non-syndromic cardiac progeria in a patient with the rare pathogenic p.Asp300Asn variant in the LMNA gene.
Marian AJ
BMC Med Genet; 2017 Oct; 18(1):116. PubMed ID: 29047356
[TBL] [Abstract][Full Text] [Related]
3. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.
Mory PB; Crispim F; Freire MB; Salles JE; Valério CM; Godoy-Matos AF; Dib SA; Moisés RS
Eur J Endocrinol; 2012 Sep; 167(3):423-31. PubMed ID: 22700598
[TBL] [Abstract][Full Text] [Related]
5. Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives.
Vigouroux C; Guénantin AC; Vatier C; Capel E; Le Dour C; Afonso P; Bidault G; Béréziat V; Lascols O; Capeau J; Briand N; Jéru I
Nucleus; 2018 Jan; 9(1):235-248. PubMed ID: 29578370
[TBL] [Abstract][Full Text] [Related]
6. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.
Decaudain A; Vantyghem MC; Guerci B; Hécart AC; Auclair M; Reznik Y; Narbonne H; Ducluzeau PH; Donadille B; Lebbé C; Béréziat V; Capeau J; Lascols O; Vigouroux C
J Clin Endocrinol Metab; 2007 Dec; 92(12):4835-44. PubMed ID: 17711925
[TBL] [Abstract][Full Text] [Related]
7. Cardiometabolic assessment of lamin A/C gene mutation carriers: a phenotype-genotype correlation.
Kwapich M; Lacroix D; Espiard S; Ninni S; Brigadeau F; Kouakam C; Degroote P; Laurent JM; Tiffreau V; Jannin A; Humbert L; Ben Hamou A; Tard C; Ben Yaou R; Lamblin N; Klug D; Richard P; Vigouroux C; Bonne G; Vantyghem MC;
Diabetes Metab; 2019 Sep; 45(4):382-389. PubMed ID: 30287275
[TBL] [Abstract][Full Text] [Related]
8. A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A.
Le Dour C; Schneebeli S; Bakiri F; Darcel F; Jacquemont ML; Maubert MA; Auclair M; Jeziorowska D; Reznik Y; Béréziat V; Capeau J; Lascols O; Vigouroux C
J Clin Endocrinol Metab; 2011 May; 96(5):E856-62. PubMed ID: 21346069
[TBL] [Abstract][Full Text] [Related]
9. LMNA-linked lipodystrophies: from altered fat distribution to cellular alterations.
Bidault G; Vatier C; Capeau J; Vigouroux C; Béréziat V
Biochem Soc Trans; 2011 Dec; 39(6):1752-7. PubMed ID: 22103520
[TBL] [Abstract][Full Text] [Related]
10. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
Vantyghem MC; Pigny P; Maurage CA; Rouaix-Emery N; Stojkovic T; Cuisset JM; Millaire A; Lascols O; Vermersch P; Wemeau JL; Capeau J; Vigouroux C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5337-46. PubMed ID: 15531479
[TBL] [Abstract][Full Text] [Related]
11. Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation.
Mory PB; Crispim F; Kasamatsu T; Gabbay MA; Dib SA; Moisés RS
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1252-6. PubMed ID: 19169477
[TBL] [Abstract][Full Text] [Related]
12. Limb-girdle muscular dystrophy with severe heart failure overlapping with lipodystrophy in a patient with LMNA mutation p.Ser334del.
Madej-Pilarczyk A; Niezgoda A; Janus M; Wojnicz R; Marchel M; Fidziańska A; Grajek S; Hausmanowa-Petrusewicz I
J Appl Genet; 2017 Feb; 58(1):87-91. PubMed ID: 27585670
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory myopathy in the context of an unusual overlapping laminopathy.
Guillín-Amarelle C; Sánchez-Iglesias S; Mera A; Pintos E; Castro-Pais A; Rodríguez-Cañete L; Pardo J; Casanueva FF; Araújo-Vilar D
Arch Endocrinol Metab; 2018 Jun; 62(3):376-382. PubMed ID: 29791652
[TBL] [Abstract][Full Text] [Related]
14. A novel autosomal recessive lipodystrophy syndrome due to homozygous
Patni N; Hatab S; Xing C; Zhou Z; Quittner C; Garg A
J Med Genet; 2020 Jun; 57(6):422-426. PubMed ID: 31857427
[TBL] [Abstract][Full Text] [Related]
15. A subtype of laminopathies: Generalized lipodystrophy-associated progeroid syndrome caused by LMNA gene c.29C>T mutation.
Huang S; Zhang Y; Zhan Z; Gong S
J Diabetes Investig; 2023 Oct; 14(10):1221-1225. PubMed ID: 37448194
[TBL] [Abstract][Full Text] [Related]
16. Laminopathies' Treatments Systematic Review: A Contribution Towards a 'Treatabolome'.
Atalaia A; Ben Yaou R; Wahbi K; De Sandre-Giovannoli A; Vigouroux C; Bonne G
J Neuromuscul Dis; 2021; 8(3):419-439. PubMed ID: 33682723
[TBL] [Abstract][Full Text] [Related]
17. A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies.
Treiber G; Flaus Furmaniuk A; Guilleux A; Medjane S; Bonfanti O; Schneebeli S; Bernard C; Le-Moullec N; Bakiri F; Pholsena M; Rollot O; Vatier C; Jarlet E; Jéru I; Lascols O; Darcel F; Domun B; Venault A; Venault S; Jacquemont ML; Doray B; Maiza JC; Cogne M; Vigouroux C; Nobécourt E
Eur J Endocrinol; 2021 Aug; 185(4):453-462. PubMed ID: 34292171
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype.
Lombardi F; Gullotta F; Columbaro M; Filareto A; D'Adamo M; Vielle A; Guglielmi V; Nardone AM; Azzolini V; Grosso E; Lattanzi G; D'Apice MR; Masala S; Maraldi NM; Sbraccia P; Novelli G
J Clin Endocrinol Metab; 2007 Nov; 92(11):4467-71. PubMed ID: 17848409
[TBL] [Abstract][Full Text] [Related]
19. A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation.
Hussain I; Patni N; Ueda M; Sorkina E; Valerio CM; Cochran E; Brown RJ; Peeden J; Tikhonovich Y; Tiulpakov A; Stender SRS; Klouda E; Tayeh MK; Innis JW; Meyer A; Lal P; Godoy-Matos AF; Teles MG; Adams-Huet B; Rader DJ; Hegele RA; Oral EA; Garg A
J Clin Endocrinol Metab; 2018 Mar; 103(3):1005-1014. PubMed ID: 29267953
[TBL] [Abstract][Full Text] [Related]
20. Heart involvement in lamin A/C related diseases.
Ben Yaou R; Gueneau L; Demay L; Stora S; Chikhaoui K; Richard P; Bonne G
Arch Mal Coeur Vaiss; 2006 Sep; 99(9):848-55. PubMed ID: 17067107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
